Neurospine, 2022 · DOI: https://doi.org/10.14245/ns.2244186.093 · Published: June 1, 2022
Biomaterial engineers are developing solutions to combat chronic diseases, but synthetic materials can cause cytotoxic immunological effects. Biomolecular and cell-based approaches are now prominent in treating spinal conditions. Alginate hydrogels, derived from brown algae, can mimic the mechanical integrity of human tissue, making them valuable in regenerative medicine and tissue engineering. This review describes the properties of alginate hydrogels and their functional outcomes in spinal cord injury, aiming to highlight their value in future treatment strategies.
Alginate hydrogels can be used as drug-delivery platforms, facilitating the injection of RhoA inhibitors and other therapeutic agents to promote neuronal reconnections and axonal regeneration.
Alginate hydrogels provide a matrix for neural stem cell growth and can be combined with other materials to create scaffolds with adjustable degradation rates.
Further research is needed to understand the biomaterial properties of alginate hydrogels to determine appropriate therapies for human subjects, including revisiting crosslinking strategies and characterizing degradation byproducts.